Details of the Drug

General Information of Drug (ID: DMDQ3XP)

• Drug Name: DNX-2401
• Synonyms: Tasadenoturev

Indication

Disease Entry	ICD 11	Status	REF
Brain cancer	2A00	Phase 2	[1]
Recurrent glioblastoma	2A00.00	Phase 2	[2]

• Drug Type: Oncolytic virus therapy
• Cross-matching ID:
  UNII: 79ME7DT193
  DrugBank ID: DB17178
  TTD ID: D8SV9R

References

• [1] ClinicalTrials.gov (NCT02798406) Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects (CAPTIVE). U.S. National Institutes of Health.
• [2] ClinicalTrials.gov (NCT02798406) Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects (CAPTIVE). U.S. National Institutes of Health.